Tomorrow Capital invests in kidney start-up VitusCare – Times of India


NEW DELHI: Tomorrow Capital, a $100 million VC fund, is investing $2.7 million in VitusCare as part of its Series A funding round.
VitusCare, a kidney care start-up founded in 2017, has emerged as a player of quality dialysis care, particularly in regions where access to such services is limited, a company statement said.
The fresh capital injection will empower VitusCare to aggressively expand its operations, with a targeted focus on deeper penetration into the hinterland.
In addition, the funding round saw participation from existing investor 1Crowd, alongside support from 3i Partners and a consortium of angel investors, totalling approximately $5 million in funding across all the funding rounds.
Tomorrow Capital, part of Lodha Ventures, has investments in healthcare, fitness and education.
India has over 5 million patients suffering from ESRD (end-stage renal disease), however, only about 5% of these receive regular dialysis with reasons ranging from affordability, lack of awareness and access. Even today, most dialysis services are skewed towards the bigger cities, further compounding this problem.


window.TimesApps = window.TimesApps || {}; var TimesApps = window.TimesApps; TimesApps.toiPlusEvents = function(config) { var isConfigAvailable = "toiplus_site_settings" in f && "isFBCampaignActive" in f.toiplus_site_settings && "isGoogleCampaignActive" in f.toiplus_site_settings; var isPrimeUser = window.isPrime; if (isConfigAvailable && !isPrimeUser) { loadGtagEvents(f.toiplus_site_settings.isGoogleCampaignActive); loadFBEvents(f.toiplus_site_settings.isFBCampaignActive); loadSurvicateJs(f.toiplus_site_settings.allowedSurvicateSections); } else { var JarvisUrl=" window.getFromClient(JarvisUrl, function(config){ if (config) { loadGtagEvents(config?.isGoogleCampaignActive); loadFBEvents(config?.isFBCampaignActive); loadSurvicateJs(config?.allowedSurvicateSections); } }) } }; })( window, document, 'script', );


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button